Try our beta test site
5 studies found for:    Open Studies | CNS lymphoma | Phase 3
Show Display Options
Rank Status Study
1 Recruiting High-dose Chemotherapy and ASCT or Consolidating Conventional Chemotherapy in Primary CNS Lymphoma
Condition: Diffuse Large B-cell-lymphoma
Interventions: Drug: Arm A (Fortecortin®-ETOPOPHOS®-IFO-cell®-CARBO-cell®);   Drug: Arm B (TEPADINA®-CARMUBRIS®-Busilvex®)
2 Recruiting Maintenance Treatment Versus Observation in Elderly Patients With PCNS Lymphoma
Condition: Primary Central Nervous System Lymphoma
Intervention: Drug: Rituximab, Methotrexate, Temozolomide
3 Recruiting Therapeutic Effects of R-IDARAM and Intrathecal Immunochemotherapy on Elderly Patients With PCNSL
Condition: Primary Central Nervous System Lymphoma
Intervention: Drug: R-IDARAM plus intrathecal chemotherapy
4 Recruiting CNS Prophylaxis in Diffuse Large B-cell Lymphoma
Condition: Diffuse Large B-cell Lymphoma
Intervention: Drug: Methotrexate
5 Recruiting Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk B Acute Lymphoblastic Leukemia and Ph-Like TKI Sensitive Mutations
Conditions: B Acute Lymphoblastic Leukemia;   Bone Necrosis;   Central Nervous System Leukemia;   Cognitive Side Effects of Cancer Therapy;   Neurotoxicity Syndrome;   Pain;   Testicular Leukemia;   Therapy-Related Toxicity;   Untreated Adult Acute Lymphoblastic Leukemia;   Untreated Childhood Acute Lymphoblastic Leukemia
Interventions: Drug: Clofarabine;   Drug: Cyclophosphamide;   Drug: Cytarabine;   Drug: Dasatinib;   Drug: Dexamethasone;   Drug: Doxorubicin Hydrochloride;   Drug: Etoposide;   Drug: Hydrocortisone Sodium Succinate;   Other: Laboratory Biomarker Analysis;   Drug: Leucovorin Calcium;   Drug: Mercaptopurine;   Drug: Methotrexate;   Drug: Pegaspargase;   Drug: Prednisone;   Radiation: Radiation Therapy;   Drug: Thioguanine;   Drug: Vincristine Sulfate

Study has passed its completion date and status has not been verified in more than two years.